AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ACHC
  4. [8-K] Acadia Healthcare Company, Inc. Reports Material Event

[8-K] Acadia Healthcare Company, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Resideo Technologies, Inc. (NYSE: REZI) filed an 8-K on 5 Aug 2025 to disclose two matters:

  • Item 2.02 鈥� Earnings: The company furnished (not filed) its Q2 2025 earnings press release as Exhibit 99. No financial figures are included in the filing; investors must consult the attached release for revenue, EPS or guidance details. Because the information is furnished, it is not subject to Exchange Act Section 18 liability and will not be incorporated by reference into other SEC documents.
  • Item 5.07 鈥� Say-on-Pay Frequency: At the 4 Jun 2025 Annual Meeting, 94.4% of votes favored holding advisory votes on executive compensation annually. On 31 Jul 2025, the Board accepted that preference and confirmed it will continue annual advisory votes going forward.

No other material transactions, financial statements or management changes were reported. Exhibit 104 contains the cover-page Inline XBRL data.

Resideo Technologies, Inc. (NYSE: REZI) ha presentato un 8-K il 5 agosto 2025 per comunicare due argomenti:

  • Voce 2.02 鈥� Risultati economici: La societ脿 ha fornito (ma non depositato) il suo comunicato stampa sui risultati del secondo trimestre 2025 come Allegato 99. Nel documento non sono inclusi dati finanziari; gli investitori devono consultare il comunicato allegato per dettagli su ricavi, utile per azione o previsioni. Poich茅 le informazioni sono fornite e non depositate, non sono soggette alla responsabilit脿 prevista dalla Sezione 18 del Exchange Act e non saranno incorporate per riferimento in altri documenti SEC.
  • Voce 5.07 鈥� Frequenza del voto consultivo sulla retribuzione: Durante l鈥橝ssemblea annuale del 4 giugno 2025, il 94,4% dei voti ha sostenuto di tenere votazioni consultive sulla retribuzione degli amministratori ogni anno. Il 31 luglio 2025, il Consiglio di Amministrazione ha accettato questa preferenza e ha confermato che continuer脿 a svolgere votazioni consultive annuali.

Non sono state segnalate altre operazioni rilevanti, bilanci o cambiamenti nella direzione. L鈥橝llegato 104 contiene i dati Inline XBRL della pagina di copertina.

Resideo Technologies, Inc. (NYSE: REZI) present贸 un 8-K el 5 de agosto de 2025 para divulgar dos asuntos:

  • Elemento 2.02 鈥� Resultados: La empresa proporcion贸 (pero no present贸) su comunicado de prensa de resultados del segundo trimestre de 2025 como Anexo 99. No se incluyen cifras financieras en la presentaci贸n; los inversores deben consultar el comunicado adjunto para obtener detalles sobre ingresos, BPA o previsiones. Debido a que la informaci贸n se proporciona y no se presenta, no est谩 sujeta a la responsabilidad seg煤n la Secci贸n 18 del Exchange Act y no se incorporar谩 por referencia en otros documentos de la SEC.
  • Elemento 5.07 鈥� Frecuencia de voto consultivo sobre compensaci贸n: En la Asamblea Anual del 4 de junio de 2025, el 94,4% de los votos apoyaron realizar votaciones consultivas sobre la compensaci贸n ejecutiva anualmente. El 31 de julio de 2025, la Junta acept贸 esta preferencia y confirm贸 que continuar谩 con votaciones consultivas anuales en adelante.

No se reportaron otras transacciones importantes, estados financieros ni cambios en la direcci贸n. El Anexo 104 contiene los datos Inline XBRL de la portada.

Resideo Technologies, Inc. (NYSE: REZI)電� 2025雲� 8鞗� 5鞚� 霊� 臧�歆� 靷暛鞚� 瓿店皽頃橁赴 鞙勴暣 8-K毳� 鞝滌稖頄堨姷雼堧嫟:

  • 頃 2.02 鈥� 鞁れ爜: 须岇偓电� 2025雲� 2攵勱赴 鞁れ爜 氤措弰鞛愲毳� Exhibit 99搿� 鞝滉车(鞝滌稖 鞎勲嫎)頄堨姷雼堧嫟. 鞝滌稖 氍胳劀鞐愲姅 鞛 靾橃箻臧� 韽暔霅橃柎 鞛堨 鞎婌溂氙�搿�, 韴瀽鞛愲摛鞚� 毵れ稖, 欤茧嫻靾滌澊鞚� 霕愲姅 臧�鞚措崢鞀� 靹鸽秬 鞝曤炒毳� 鞙勴暣 觳秬霅� 氤措弰鞛愲毳� 彀胳“頃挫暭 頃╇媹雼�. 鞝滉车霅� 鞝曤炒電� 鞝滌稖霅� 瓴冹澊 鞎勲媹氙�搿� Exchange Act 靹轨厴 18鞚� 毂呾瀯 雽�靸侅澊 鞎勲媹氅� 雼るジ SEC 氍胳劀鞐� 彀胳“搿� 韽暔霅橃 鞎婌姷雼堧嫟.
  • 頃 5.07 鈥� 氤挫垬鞐� 甏�頃� 鞛愲 韴憸 牍堧弰: 2025雲� 6鞗� 4鞚� 鞐半齑濏殞鞐愳劀 94.4%鞚� 韴憸鞛愱皜 鞛勳洂 氤挫垬鞐� 雽�頃� 鞛愲 韴憸毳� 毵る厔 鞁れ嫓頃橂姅 瓴冹棎 彀劚頄堨姷雼堧嫟. 2025雲� 7鞗� 31鞚�, 鞚挫偓須岆姅 鞚� 靹犿樃毳� 靾橃毄頃橁碃 鞎烄溂搿滊弰 毵る厔 鞛愲 韴憸毳� 瓿勳啀 鞁れ嫓頃� 瓴冹瀯鞚� 頇曥澑頄堨姷雼堧嫟.

旮绊儉 欷戩殧頃� 瓯半灅, 鞛鞝滍憸 霕愲姅 瓴届榿歆� 氤�瓴� 靷暛鞚� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�. Exhibit 104鞐愲姅 響滌 韼橃澊歆�鞚� Inline XBRL 雿办澊韯瓣皜 韽暔霅橃柎 鞛堨姷雼堧嫟.

Resideo Technologies, Inc. (NYSE: REZI) a d茅pos茅 un 8-K le 5 ao没t 2025 pour divulguer deux sujets :

  • Point 2.02 鈥� R茅sultats : La soci茅t茅 a fourni (mais pas d茅pos茅) son communiqu茅 de presse des r茅sultats du deuxi猫me trimestre 2025 en tant qu鈥橢xhibit 99. Aucun chiffre financier n鈥檈st inclus dans le d茅p么t ; les investisseurs doivent consulter le communiqu茅 joint pour les d茅tails sur les revenus, le BPA ou les pr茅visions. 脡tant donn茅 que l鈥檌nformation est fournie et non d茅pos茅e, elle n鈥檈st pas soumise 脿 la responsabilit茅 en vertu de la Section 18 du Exchange Act et ne sera pas incorpor茅e par r茅f茅rence dans d鈥檃utres documents de la SEC.
  • Point 5.07 鈥� Fr茅quence du vote consultatif sur la r茅mun茅ration : Lors de l鈥檃ssembl茅e g茅n茅rale annuelle du 4 juin 2025, 94,4% des votes ont soutenu la tenue de votes consultatifs sur la r茅mun茅ration des dirigeants annuellement. Le 31 juillet 2025, le conseil d鈥檃dministration a accept茅 cette pr茅f茅rence et confirm茅 qu鈥檌l continuera 脿 organiser des votes consultatifs annuels 脿 l鈥檃venir.

Aucune autre transaction importante, 茅tats financiers ou changement de direction n鈥檃 茅t茅 signal茅. L鈥橢xhibit 104 contient les donn茅es Inline XBRL de la page de couverture.

Resideo Technologies, Inc. (NYSE: REZI) reichte am 5. August 2025 ein 8-K ein, um zwei Angelegenheiten offenzulegen:

  • Punkt 2.02 鈥� Ergebnisse: Das Unternehmen stellte (nicht einreichte) seine Pressemitteilung zu den Ergebnissen des zweiten Quartals 2025 als Anlage 99 zur Verf眉gung. Im Einreichungsdokument sind keine Finanzzahlen enthalten; Investoren m眉ssen die beigef眉gte Mitteilung f眉r Details zu Umsatz, Gewinn pro Aktie oder Prognosen konsultieren. Da die Informationen bereitgestellt und nicht eingereicht wurden, unterliegen sie nicht der Haftung gem盲脽 Section 18 des Exchange Act und werden nicht durch Verweis in anderen SEC-Dokumenten aufgenommen.
  • Punkt 5.07 鈥� H盲ufigkeit der Say-on-Pay-Abstimmung: Bei der Hauptversammlung am 4. Juni 2025 unterst眉tzten 94,4% der Stimmen die j盲hrliche Durchf眉hrung von Beratungsabstimmungen zur Verg眉tung der Gesch盲ftsleitung. Am 31. Juli 2025 akzeptierte der Vorstand diese Pr盲ferenz und best盲tigte, dass k眉nftig j盲hrliche Beratungsabstimmungen fortgef眉hrt werden.

Es wurden keine weiteren wesentlichen Transaktionen, Abschl眉sse oder Management盲nderungen gemeldet. Anlage 104 enth盲lt die Inline-XBRL-Daten der Titelseite.

Positive
  • Board confirms annual advisory votes, demonstrating responsiveness to 94.4% shareholder support and reinforcing good corporate governance.
Negative
  • None.

Insights

TL;DR: Procedural 8-K; earnings press release furnished, board aligns with shareholder preference鈥攍imited market impact.

The filing is largely administrative. The Q2 2025 earnings details are referenced but not disclosed, so investors must await the press release for quantitative insight. Furnishing rather than filing limits legal exposure. Governance-wise, a 94.4% vote for annual say-on-pay is strong; the Board鈥檚 decision to comply maintains shareholder alignment and should be viewed positively, albeit routine. Absent financial metrics or strategic actions, the disclosure is unlikely to affect valuation or trading volumes.

Resideo Technologies, Inc. (NYSE: REZI) ha presentato un 8-K il 5 agosto 2025 per comunicare due argomenti:

  • Voce 2.02 鈥� Risultati economici: La societ脿 ha fornito (ma non depositato) il suo comunicato stampa sui risultati del secondo trimestre 2025 come Allegato 99. Nel documento non sono inclusi dati finanziari; gli investitori devono consultare il comunicato allegato per dettagli su ricavi, utile per azione o previsioni. Poich茅 le informazioni sono fornite e non depositate, non sono soggette alla responsabilit脿 prevista dalla Sezione 18 del Exchange Act e non saranno incorporate per riferimento in altri documenti SEC.
  • Voce 5.07 鈥� Frequenza del voto consultivo sulla retribuzione: Durante l鈥橝ssemblea annuale del 4 giugno 2025, il 94,4% dei voti ha sostenuto di tenere votazioni consultive sulla retribuzione degli amministratori ogni anno. Il 31 luglio 2025, il Consiglio di Amministrazione ha accettato questa preferenza e ha confermato che continuer脿 a svolgere votazioni consultive annuali.

Non sono state segnalate altre operazioni rilevanti, bilanci o cambiamenti nella direzione. L鈥橝llegato 104 contiene i dati Inline XBRL della pagina di copertina.

Resideo Technologies, Inc. (NYSE: REZI) present贸 un 8-K el 5 de agosto de 2025 para divulgar dos asuntos:

  • Elemento 2.02 鈥� Resultados: La empresa proporcion贸 (pero no present贸) su comunicado de prensa de resultados del segundo trimestre de 2025 como Anexo 99. No se incluyen cifras financieras en la presentaci贸n; los inversores deben consultar el comunicado adjunto para obtener detalles sobre ingresos, BPA o previsiones. Debido a que la informaci贸n se proporciona y no se presenta, no est谩 sujeta a la responsabilidad seg煤n la Secci贸n 18 del Exchange Act y no se incorporar谩 por referencia en otros documentos de la SEC.
  • Elemento 5.07 鈥� Frecuencia de voto consultivo sobre compensaci贸n: En la Asamblea Anual del 4 de junio de 2025, el 94,4% de los votos apoyaron realizar votaciones consultivas sobre la compensaci贸n ejecutiva anualmente. El 31 de julio de 2025, la Junta acept贸 esta preferencia y confirm贸 que continuar谩 con votaciones consultivas anuales en adelante.

No se reportaron otras transacciones importantes, estados financieros ni cambios en la direcci贸n. El Anexo 104 contiene los datos Inline XBRL de la portada.

Resideo Technologies, Inc. (NYSE: REZI)電� 2025雲� 8鞗� 5鞚� 霊� 臧�歆� 靷暛鞚� 瓿店皽頃橁赴 鞙勴暣 8-K毳� 鞝滌稖頄堨姷雼堧嫟:

  • 頃 2.02 鈥� 鞁れ爜: 须岇偓电� 2025雲� 2攵勱赴 鞁れ爜 氤措弰鞛愲毳� Exhibit 99搿� 鞝滉车(鞝滌稖 鞎勲嫎)頄堨姷雼堧嫟. 鞝滌稖 氍胳劀鞐愲姅 鞛 靾橃箻臧� 韽暔霅橃柎 鞛堨 鞎婌溂氙�搿�, 韴瀽鞛愲摛鞚� 毵れ稖, 欤茧嫻靾滌澊鞚� 霕愲姅 臧�鞚措崢鞀� 靹鸽秬 鞝曤炒毳� 鞙勴暣 觳秬霅� 氤措弰鞛愲毳� 彀胳“頃挫暭 頃╇媹雼�. 鞝滉车霅� 鞝曤炒電� 鞝滌稖霅� 瓴冹澊 鞎勲媹氙�搿� Exchange Act 靹轨厴 18鞚� 毂呾瀯 雽�靸侅澊 鞎勲媹氅� 雼るジ SEC 氍胳劀鞐� 彀胳“搿� 韽暔霅橃 鞎婌姷雼堧嫟.
  • 頃 5.07 鈥� 氤挫垬鞐� 甏�頃� 鞛愲 韴憸 牍堧弰: 2025雲� 6鞗� 4鞚� 鞐半齑濏殞鞐愳劀 94.4%鞚� 韴憸鞛愱皜 鞛勳洂 氤挫垬鞐� 雽�頃� 鞛愲 韴憸毳� 毵る厔 鞁れ嫓頃橂姅 瓴冹棎 彀劚頄堨姷雼堧嫟. 2025雲� 7鞗� 31鞚�, 鞚挫偓須岆姅 鞚� 靹犿樃毳� 靾橃毄頃橁碃 鞎烄溂搿滊弰 毵る厔 鞛愲 韴憸毳� 瓿勳啀 鞁れ嫓頃� 瓴冹瀯鞚� 頇曥澑頄堨姷雼堧嫟.

旮绊儉 欷戩殧頃� 瓯半灅, 鞛鞝滍憸 霕愲姅 瓴届榿歆� 氤�瓴� 靷暛鞚� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�. Exhibit 104鞐愲姅 響滌 韼橃澊歆�鞚� Inline XBRL 雿办澊韯瓣皜 韽暔霅橃柎 鞛堨姷雼堧嫟.

Resideo Technologies, Inc. (NYSE: REZI) a d茅pos茅 un 8-K le 5 ao没t 2025 pour divulguer deux sujets :

  • Point 2.02 鈥� R茅sultats : La soci茅t茅 a fourni (mais pas d茅pos茅) son communiqu茅 de presse des r茅sultats du deuxi猫me trimestre 2025 en tant qu鈥橢xhibit 99. Aucun chiffre financier n鈥檈st inclus dans le d茅p么t ; les investisseurs doivent consulter le communiqu茅 joint pour les d茅tails sur les revenus, le BPA ou les pr茅visions. 脡tant donn茅 que l鈥檌nformation est fournie et non d茅pos茅e, elle n鈥檈st pas soumise 脿 la responsabilit茅 en vertu de la Section 18 du Exchange Act et ne sera pas incorpor茅e par r茅f茅rence dans d鈥檃utres documents de la SEC.
  • Point 5.07 鈥� Fr茅quence du vote consultatif sur la r茅mun茅ration : Lors de l鈥檃ssembl茅e g茅n茅rale annuelle du 4 juin 2025, 94,4% des votes ont soutenu la tenue de votes consultatifs sur la r茅mun茅ration des dirigeants annuellement. Le 31 juillet 2025, le conseil d鈥檃dministration a accept茅 cette pr茅f茅rence et confirm茅 qu鈥檌l continuera 脿 organiser des votes consultatifs annuels 脿 l鈥檃venir.

Aucune autre transaction importante, 茅tats financiers ou changement de direction n鈥檃 茅t茅 signal茅. L鈥橢xhibit 104 contient les donn茅es Inline XBRL de la page de couverture.

Resideo Technologies, Inc. (NYSE: REZI) reichte am 5. August 2025 ein 8-K ein, um zwei Angelegenheiten offenzulegen:

  • Punkt 2.02 鈥� Ergebnisse: Das Unternehmen stellte (nicht einreichte) seine Pressemitteilung zu den Ergebnissen des zweiten Quartals 2025 als Anlage 99 zur Verf眉gung. Im Einreichungsdokument sind keine Finanzzahlen enthalten; Investoren m眉ssen die beigef眉gte Mitteilung f眉r Details zu Umsatz, Gewinn pro Aktie oder Prognosen konsultieren. Da die Informationen bereitgestellt und nicht eingereicht wurden, unterliegen sie nicht der Haftung gem盲脽 Section 18 des Exchange Act und werden nicht durch Verweis in anderen SEC-Dokumenten aufgenommen.
  • Punkt 5.07 鈥� H盲ufigkeit der Say-on-Pay-Abstimmung: Bei der Hauptversammlung am 4. Juni 2025 unterst眉tzten 94,4% der Stimmen die j盲hrliche Durchf眉hrung von Beratungsabstimmungen zur Verg眉tung der Gesch盲ftsleitung. Am 31. Juli 2025 akzeptierte der Vorstand diese Pr盲ferenz und best盲tigte, dass k眉nftig j盲hrliche Beratungsabstimmungen fortgef眉hrt werden.

Es wurden keine weiteren wesentlichen Transaktionen, Abschl眉sse oder Management盲nderungen gemeldet. Anlage 104 enth盲lt die Inline-XBRL-Daten der Titelseite.

false 0001520697 0001520697 2025-08-04 2025-08-04
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
 
FORM 8-K
 
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported): August 5, 2025 (August 4, 2025)
 
 
Acadia Healthcare Company, Inc.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware
  
001-35331
  
45-2492228
(State or Other Jurisdiction of Incorporation)
  
(Commission File Number)
  
(IRS Employer Identification No.)
 
6100 Tower Circle, Suite 1000
Franklin, Tennessee
(Address of Principal Executive Offices)
  
37067
(Zip Code)
 
(615) 861-6000
(Registrant’s Telephone Number, including Area Code)
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading Symbol
  
Name of each exchange on which registered
Common Stock, $0.01 par value
  
ACHC
  
NASDAQ Global Select Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company         ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.       ☐
 
 
 
Item 2.02         Results of Operations and Financial Condition.
 
On August 5, 2025, Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) issued a press release announcing, among other things, Acadia’s operating and financial results for the second quarter ended June 30, 2025. The press release is furnished herewith as Exhibit 99 hereto and is incorporated herein by reference.
 
Item 5.02         Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
Departure of Executive Vice President and Chief Financial Officer
 
On August 4, 2025, Heather Dixon notified the Company of her resignation as Executive Vice President and Chief Financial Officer, effective August 15, 2025. Ms. Dixon’s separation from the Company is not a result of any disagreement with other members of the Company’s management or the Company’s external auditor.
 
Appointment of Interim Chief Financial Officer
 
The Board of Directors of the Company has appointed Timothy Sides to serve as the Company’s Interim Chief Financial Officer (“Interim CFO”), effective August 16, 2025. The Company intends to conduct a nationwide search for a permanent chief financial officer. 
 
Mr. Sides, age 47, has been employed by the Company since February 2020, most recently as Senior Vice President, Operations Finance. Prior to that, Mr. Sides served in the role of Operations Group Chief Financial Officer. Prior to joining the Company, Mr. Sides was employed in various financial roles at Universal Health Services, Inc. from November 2013 to February 2020.
 
There is no arrangement or understanding between Mr. Sides and any other person pursuant to which Mr. Sides was selected as the Company’s Interim CFO. Mr. Sides has no family relationships with any director, executive officer or person nominated or chosen by the Company to become a director or executive officer of the Company. Mr. Sides is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
 
Mr. Sides’ annual base salary is $445,000 and, for his service as Interim CFO, he will receive a supplemental payment of $6,140 for every week that he serves as Interim CFO. Mr. Sides will continue to be eligible for the cash incentive program established for his prior role for 2025, pursuant to which he is eligible to receive an amount equal to 75% of his base salary at target level performance for the year. Mr. Sides’ supplemental payment will be included when calculating his cash incentive for 2025. Mr. Sides is eligible for benefits generally available to officers of the Company.
 
Mr. Sides’ previous cash retention award opportunity is being amended in connection with his appointment as Interim CFO to provide an opportunity to earn a cash retention bonus of $500,000 if Mr. Sides remains continuously employed by the Company through March 31, 2026. Pursuant to the terms of the cash retention award agreement, if the Company terminates his employment without cause prior to March 31, 2026, then Mr. Sides shall be entitled to the full amount of the retention bonus provided that he executes a customary release of claims.
 
2
 
 
Mr. Sides is party to a Severance Agreement with the Company, dated as of April 29, 2022. The Severance Agreement provides that if Mr. Sides is terminated without cause or resigns with good reason, he is generally entitled to receive (subject to the satisfaction of certain conditions) (i) a severance payment equal to 12 months of his base salary, payable under the Company’s regular payroll practices; (ii) accelerated vesting of restricted stock awards; (iii) any unused and unpaid time off accrued through the termination date; and (iv) an amount equal to the cost of the premiums for continued health and dental insurance for Mr. Sides and his dependents in accordance with COBRA for 12 months. The Severance Agreement contains restrictive covenants pursuant to which Mr. Sides has agreed not to compete with the Company during his period of employment and for 12 months thereafter. The agreement also contains non-solicitation and non-disparagement covenants consistent with other officers of the Company.
 
The foregoing descriptions of the cash retention award agreement and the Severance Agreement do not purport to be complete and are qualified in their entirety by the terms and conditions of the applicable agreements, as amended, the forms of which have been or will be filed as exhibits to the Company’s reports filed with the Securities and Exchange Commission.
 
Item 9.01         Financial Statements and Exhibits.
 
(d)
Exhibits
 
99
Press Release of Acadia Healthcare Company, Inc., dated August 5, 2025
 
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
3
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: August 5, 2025
ACADIA HEALTHCARE COMPANY, INC.
By:
/s/ Brian P. Farley
Brian P. Farley
Executive Vice President, Secretary and General Counsel
       
4

Source:

FAQ

When did Resideo (REZI) release its Q2 2025 earnings?

The earnings press release was issued on August 5, 2025 and is attached as Exhibit 99.

What items are covered in Resideos August 5, 2025 8-K?

Item 2.02 (Results of Operations 鈥� earnings press release) and Item 5.07 (say-on-pay frequency vote outcome).

How did shareholders vote on the frequency of executive compensation advisory votes?

94.4% of shares voted favored conducting the advisory vote annually.

What decision did the Board make regarding future say-on-pay votes?

On July 31, 2025 the Board decided to continue holding the advisory vote on executive compensation every year.

Is the Q2 2025 earnings information considered 'filed' with the SEC?

No. It is furnished under Item 2.02, meaning it is not subject to Section 18 liability and is excluded from other filings by reference.
Stock ACHC logo
Acadia Healthcar

NASDAQ:ACHC

ACHC Rankings

#2871 Ranked by Market Cap
N/A Ranked by Dividends

ACHC Latest News

Aug 5, 2025
Acadia Healthcare Reports Second Quarter 2025 Results
Jul 18, 2025
Acadia Healthcare Announces Date for Second Quarter 2025 Earnings Release
May 12, 2025
Acadia Healthcare Reports First Quarter 2025 Results
May 8, 2025
Acadia Healthcare to Participate in BofA Securities Health Care Conference
Apr 16, 2025
Acadia Healthcare Announces Date for First Quarter 2025 Earnings Release

ACHC Latest SEC Filings

Aug 5, 2025
[10-Q] Acadia Healthcare Company, Inc. Quarterly Earnings Report
Jul 29, 2025
[Form 4] Acadia Healthcare Company, Inc. Insider Trading Activity
Jul 29, 2025
[Form 4] Acadia Healthcare Company, Inc. Insider Trading Activity

ACHC Stock Data

2.00B
90.70M
1.75%
105.73%
11.5%
Medical Care Facilities
Services-specialty Outpatient Facilities, Nec
United States
FRANKLIN